BioSpace News Archive

At their August 5 meeting, the Board of Education celebrated the Battelle National Biodefense Institute’s award to Frederick County Public Schools of $50,000 for science, technology, engineering and math challenge grants. During a 6-week open competition, teachers from elementary, middle and high schools developed and submitted 16 STEM grant proposals. Of the 16, nine were selected as winners. Each of the 9 selected p

A nationwide advocacy group is bringing together top public health officials, water management experts and noted advocate Erin Brockovich in August to continue its important work on reopening the country safely during and after the coronavirus shutdowns.

As national health care spending rises, emergency care stands out for its role in helping patients avoid costly care in other parts of the hospital.

Humana Pharmacy, a division of Humana Inc., has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study.

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced Chief Executive Officer, Patrick Jordan, was named Life Sciences CEO of the Year by the Triangle Business Journal (TBJ).

Renowned professor and orthopedic surgeon known for her extensive research and care of children with cerebral palsy, scoliosis and clubfoot joins the Children’s Colorado team

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced that it will host a conference call to discuss its Q2 2020 financial results

Currant Flavor Tauri-Gum™ is Cannabigerol Infused - Each Piece of Chewing Gum Contains 15mg CBG

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, reported recent business highlights, anticipated upcoming milestones, and financial results for the second quarter and first half of 2020.